Boxer Dog Health Guide: ARVC Cardiomyopathy, Cancer Risk & Genetic Screening
Published: 2026-05-31 · Updated: 2026-06-12
The Boxer holds a tragic distinction in veterinary cardiology: Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)—also known as Boxer Cardiomyopathy—is so prevalent in the breed that it was originally described as 'Boxer heart disease.' Caused by a deletion in the STRN...
Breed Health Profile
| Profile Type | Breed Health Profile |
|---|---|
| Common Triggers / Risk Factors | Genetic arrhythmia mutation, Cancer predisposition, Age-related onset |
| Owner Mindset | Proactive health management, Informed ownership |
The Boxer holds a tragic distinction in veterinary cardiology: Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)—also known as Boxer Cardiomyopathy—is so prevalent in the breed that it was originally described as 'Boxer heart disease.' Caused by a deletion in the STRN gene, ARVC causes the heart muscle to be replaced by fatty-fibrous tissue, leading to life-threatening ventricular arrhythmias. An estimated 20-40% of Boxers carry at least one copy of the mutation. Unlike dilated cardiomyopathy (DCM) which causes pump failure, ARVC kills through sudden cardiac death—a Boxer can collapse and die during exercise with no prior symptoms.
Genetic Health Table
| Condition | Susceptibility Genes | Incidence Rate | Early Screening |
|---|---|---|---|
| Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) | STRN (8bp deletion, autosomal dominant, incomplete penetrance) | 20-40% carry mutation; 5-10% develop clinical disease | DNA test (UC Davis VGL, Embark) + 24-hour Holter monitor annually starting at age 3 |
| Mast Cell Tumors (MCT) | c-KIT (activating mutations, somatic — not inherited in simple pattern) | Boxers have 4-8× elevated risk vs general dog population | Monthly full-body skin palpation; fine needle aspirate of ANY new lump immediately |
| Lymphoma | Polygenic (elevated breed risk) | 4-6% lifetime risk (2-3× general population) | Monthly lymph node palpation; CBC + chemistry annually from age 5 |
| Hip Dysplasia | Polygenic | 8-10% | OFA or PennHIP radiograph at 24 months |
| Aortic Stenosis / SAS | Polygenic (suspected) | 2-3% | Echocardiogram with Doppler at 12-18 months |
| Hypothyroidism | Polygenic (autoimmune thyroiditis) | 5-8% | TSH + T4 + TgAA panel annually from age 4 |
ARVC screening protocol: A single DNA test identifies the STRN mutation—but 24-hour Holter monitoring remains essential because NOT all affected Boxers carry the known mutation. The gold standard is: DNA test at any age + annual 24-hour Holter starting at age 3 + echocardiogram. Boxers with >50 VPCs (ventricular premature complexes) in 24 hours are at significantly elevated risk for sudden death and typically require anti-arrhythmic medication (sotalol or mexiletine). Omega-3 fatty acid supplementation (EPA/DHA) has been shown in clinical studies to reduce ventricular arrhythmia burden in affected Boxers.
Related Topics
References & Further Reading
- ASPCA. Common Dog & Cat Behavior Issues. aspca.org/pet-care
- American Animal Hospital Association (AAHA). Pet Behavior Resources. aaha.org
- Journal of Veterinary Behavior (Elsevier). Clinical Applications and Research. sciencedirect.com
- American Veterinary Society of Animal Behavior (AVSAB). Position Statements & Resources. avsab.org
Citations are provided for educational reference. Content is reviewed periodically but does not replace professional veterinary advice. If your pet shows signs of illness, contact a licensed veterinarian immediately.